Join us to learn about sclerotherapy, an innovative treatment offering hope to HHT patients suffering from chronic nosebleeds. Dr. Jay Piccirillo, ENT at Washington University, will explain how this minimally invasive therapy works, its benefits, who qualifies, where patients can receive this treatment, and what to expect. Take a step towards relief and control—register today! This 40 minute presentation will be followed by 20 minutes of Q&A.